Referral Banners

Wednesday, October 8, 2014

Business Today: Chimerix, Symantec rise in early trading

Click to View in Browser
Reuters Election 2012 Daily round-up of the day's top news from the campaign trail, the White House and all the politics in between
Chimerix, Symantec rise in early trading
NEW YORK (Reuters) - Chimerix Inc shares were briskly traded before the opening bell on Wednesday as an experimental oral antiviral drug improved the survival rate of patients with a certain type of respiratory infection, according to preliminary data.
Growth worries grip world's stock, oil markets
LONDON (Reuters) - European stock markets fell for a second day on Wednesday, pushing world share indices back toward their lowest in six months as concern mounts over global economic growth.
Exclusive: Actavis plans new merger approach for Allergan - sources
NEW YORK (Reuters) - Actavis Plc plans to approach Allergan Inc again about a potential merger, as the Botox maker warms up to the possibility of a sale, people familiar with the matter said on Tuesday.
The Big Data bounty: U.S. startups challenge agribusiness giants
MAPLE PARK Ill. (Reuters) - Chris Gould's combine cab is loaded like the cockpit of a fighter jet he used to fly as he harvests soybeans in northern Illinois, steered by satellites, four video screens glowing with up to minute updates about his crop and the work's progress.
GT Advanced bankruptcy offers warning to Apple suppliers
SAN FRANCISCO/TOKYO (Reuters) - The financial implosion of Apple Inc supplier GT Advanced Technologies Inc this week offers a dramatic illustration of how the iPhone maker can put the screws to suppliers willing to take a short-term risk for future riches.
Adidas beefs up management as it seeks to revive fortunes
BERLIN (Reuters) - German sportswear firm Adidas has appointed two new senior managers as part of an ongoing overhaul of its top leadership aimed at making the firm quicker to respond to consumer trends to keep up with bigger rival Nike .
Shareholder group critical as Roche and Novartis chiefs top Swiss pay table
ZURICH (Reuters) - The bosses of drugmakers Roche and Novartis both earned more than 13 million Swiss francs ($13.6 million) last year, according to a study published on Wednesday, 18 months after the Swiss voted for some of the world's strictest controls on executive pay.
Air France puts cost of pilots strike at 500 million euros
PARIS (Reuters) - Air France-KLM has put the total cost of last month's two-week pilots strike at 500 million euros ($632 million), enough to wipe more than a fifth off the group's estimated full-year core profit and sending its shares to a 13-month low.
South Korea powers up downtown duty-free sales as China tourism magnet
SEOUL (Reuters) - Already the world's biggest duty-free market, South Korea said on Wednesday it will issue more licenses for downtown duty-free shops, doubling down on a strategy that has helped it outstrip regional rivals seeking to reel in shopaholic Chinese tourists.
Exclusive: Russia's VTB Capital closes in on Roberto Cavalli- sources
LONDON/MOSCOW (Reuters) - VTB Capital, the investment arm of sanctioned Russian lender VTB Bank , has made a cash payment to secure a deal to buy most of Italian fashion house Roberto Cavalli before the end of November, two sources familiar with the situation said.
Related Video
Breakingviews: Russia rouble dead end
Chinese obsession with bling not just a fling
Economic News
OECD sees stable growth for major economies, weaker in euro zone
EU's incoming economic chief Moscovici ready to fine France if necessary
A daily digest of breaking business news, coverage of the US economy, major corporate news and the financial markets. Register Today  
The latest Reuters articles on M&A, IPOs, private equity, hedge funds and regulatory updates delivered to your inbox each day. Register Today  
- 3 Times Square New York, NY 10036 USA © Copyright 2010 Thomson Reuters
Ensure delivery of Reuters Newsmails, add to your address book. Details
Subscribe to other Reuters newsletters.
Unsubscribe from this newsletter.
Follow us on Twitter facebook Friend us on Facebook Forward this newsletter to a friend Forward to a friend

No comments: